Retatrutide

Next-Generation Triple Agonist

Retatrutide is an investigational research peptide studied for its unique triple receptor activity targeting GLP-1, GIP, and glucagon pathways. Its multi-receptor mechanism has made it a major focus of metabolic and obesity research due to its potential to influence energy balance, glucose regulation, and body composition in experimental settings.  

Every Helix Aura vial is manufactured to demanding quality standards and undergoes independent third-party purity testing to ensure exceptional consistency for laboratory research.

Product Features

• 10mg lyophilized peptide
• Third-party purity tested
• USA sourced
• Research use only
• Premium laboratory quality